* Swiss drugmaker's $4.5bn approach deemed inadequate
* US group denies soliciting proposal
By James Politi in New York and Haig Simonian in Zurich
Published: September 6 2005 03:00 | Last updated: September 6 2005 03:00
* Swiss drugmaker's $4.5bn approach deemed inadequate
* US group denies soliciting proposal